サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1423453

酒石酸スフェアの世界市場：2023年～2030年

Global Tartaric Acid Spheres Market - 2023-2030

出版日
ページ情報
英文 197 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
酒石酸スフェアの世界市場：2023年～2030年
出版日: 2024年02月09日
発行: DataM Intelligence
ページ情報: 英文 197 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

概要

世界の酒石酸スフェアの市場規模は、2022年に3,850万米ドルに達し、2023年～2030年の予測期間中にCAGR7.4％で成長し、2030年には6,810万米ドルに達すると予測されています。

大規模な酒石酸誘導体事業の中で、世界の酒石酸スフェア市場はニッチ市場です。酒石酸スフェアと呼ばれる特殊な球状粒子は、主に製薬業界において、放出制御型医薬製剤や新規ドラッグデリバリー法への応用が期待されています。

強力な製薬分野と厳格な規制を持つ欧州は、酒石酸スフェア市場の軌道に影響を与える好位置にあります。酒石酸スフェアは、同地域が医薬品製剤の革新、研究開発に注力していることから、最先端のドラッグデリバリーシステムに応用される可能性があります。そのため、欧州は世界の製品市場で大きなシェアを占めています。

力学

ドラッグデリバリーシステムに革命をもたらす酒石酸スフェア

特定の薬物投与と高度なドラッグデリバリー技術に対するニーズの高まりが、酒石酸スフェア市場を牽引しています。製薬会社は、患者のコンプライアンス向上、精密投与、有効性向上を実現する新しい製剤への投資を増やしています。

酒石酸スフェアは、標的薬物投与や放出制御用途の潜在的な利点があるため、このアプローチの結果として注目を集めています。酒石酸スフェアの研究開発は、新規のドラッグデリバリーシステムを構築することへの関心が高まった結果、拡大しています。研究機関や製薬企業が、さまざまな薬物に対するこれらの分野の可能性を調査するために投資を行った結果、市場が拡大しています。

先進ドラッグデリバリーシステムに対する需要の高まり

製薬企業は、インプラント、パッチ、経口フィルム、ナノ粒子など、薬剤の溶解性、放出制御、安定性を高める新規製剤に注力しています。ノバルティスは、眼疾患に対して薬物の放出を延長する徐放性インプラントであるOZURDEXなど、最先端の眼用インプラントを開発しました。

全身への曝露を最小限に抑え、副作用を最小限に抑えるため、メーカー各社は薬剤を作用部位に直接運ぶことができるデバイスを開発しています。例えば、Sun Pharmaceutical Industriesのような企業は、健康な組織への損傷を最小限に抑えながら、特にがん治療のために、オーダーメイドのデリバリーを提供するリポソーム型ドラッグデリバリー法を開発しています。

厳しい規制の枠組み

厳格な規制により、最高水準の安全性と有効性を備えたドラッグデリバリーシステムのみが市場に出回ることになります。こうした規則を考慮することで、患者、利害関係者、医療従事者の信頼と信用が築かれます。その結果、市場の拡大とコンプライアンス製品の受け入れが促進されます。規制を遵守するために、生産者は製品を差別化し、革新しなければなりません。企業は研究開発に資金を投じ、法的要件に準拠した最先端のドラッグデリバリーソリューションを生み出します。その結果、マーケットプレースでの競合優位性をもたらす最先端・先端技術が発売されます。

より厳格な規則は、要件に準拠するための手段や専門知識が不足している可能性のある新興企業や設立間もない企業にとって、しばしば参入障壁となります。必要な資源や専門知識を備えた、より大規模で確立された企業の設立を促進することで、イノベーションを支援し、市場拡大を推進する労働環境を育成することができます。

サステナビリティとグリーンイニシアティブ

持続可能性の目標は、酒石酸スフェアの生態学的に持続可能な製造手順の開発と一致しています。環境に優しい製品を求める消費者の需要に対応し、市場の魅力を向上させる一つの方法は、効率的で低負荷の生産プロセスを開発すること、グリーンケミカルのコンセプトに従うこと、あるいは再生可能資源を使用することです。

酒石酸スフェアの製造にバイオベースまたは生分解性原料を検討することは、石油化学から生成される供給源への依存を減らし、より持続可能なサプライチェーンを構築するのに役立ちます。再生可能資源への移行は持続可能性の目標に沿うものであり、環境意識の高い顧客を引きつける可能性があります。

酒石酸スフェアの製造過程における廃棄物発生、エネルギー使用、排出の削減を目指すグリーンイニシアチブは、環境にとって有益です。企業は、持続可能な取り組みを実施することで、競争上の優位性を獲得し、環境にやさしい製品を重視する市場に参入することができます。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

  • 影響要因
    • 促進要因
      • ドラッグデリバリーシステムに革命をもたらす酒石酸スフェア
      • 高度なドラッグデリバリーシステムに対する需要の高まり
    • 抑制要因
      • 厳しい規制枠組み
    • 機会
      • 持続可能性とグリーンイニシアチブ
    • 影響分析

第5章 業界分析

  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 価格分析
  • 規制分析
  • ロシア・ウクライナ戦争の影響分析
  • DMIの見解

第6章 COVID-19分析

第7章 粒子サイズ別

  • 100～350マイクロメートル
  • 200～355マイクロメートル
  • 300～500マイクロメートル
  • 400～600マイクロメートル
  • 500～700マイクロメートル
  • 600～800マイクロメートル

第8章 販売チャネル別

  • 直販
  • 流通業者／卸売業者
  • オンラインプラットフォーム／小売業者

第9章 エンドユーザー別

  • 医薬品製造
  • 食品加工
  • 化粧品・パーソナルケア
  • 化学産業
  • その他

第10章 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • ロシア
    • その他欧州
  • 南米
    • ブラジル
    • アルゼンチン
    • その他南米
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • オーストラリア
    • その他アジア太平洋
  • 中東・アフリカ

第11章 競合情勢

  • 競合シナリオ
  • 市況/シェア分析
  • M&A分析

第12章 企業プロファイル

  • Tate & Lyle plc
    • 会社概要
    • 粒子径ポートフォリオと説明
    • 財務概要
    • 主な発展
  • Merck KGaA
  • Neutral Spheres
  • Pharmatrans-Sanaq AG
  • Ingredient Pharm
  • Tarac Technologies
  • Tartaros Gonzalo Castello S.L
  • SPI Pharma

第13章 付録

目次
Product Code: CH7900

Overview

Global Tartaric Acid Spheres Market reached US$ 38.5 million in 2022 and is expected to reach US$ 68.1 million by 2030, growing with a CAGR of 7.4% during the forecast period 2023-2030.

Within the larger tartaric acid derivatives operations, the global tartaric acid spheres market is a niche market. Specialized spherical particles called tartaric acid spheres have potential applications in controlled-release medicine formulations and novel drug delivery methods, mostly in the pharmaceutical industry.

With its strong pharmaceutical sector and strict regulations, Europe is well-positioned to influence the trajectory of the tartaric acid spheres market. Tartaric Acid Spheres may find application in state-of-the-art drug delivery systems due to the region's focus on innovation, research and development in drug formulations. Therefore, Europe accounts for the significant market shares in the global product market.

Dynamics

Tartaric Acid Spheres Revolutionizing Drug Delivery Systems

The increasing need for specific medication administration and advanced drug delivery technologies is driving the tartaric acid sphere market. Pharmaceutical companies are investing more and more in new formulations that provide better patient compliance, precision dosing and increased efficacy.

Tartaric acid spheres have gained attention as a result of this approach because of their potential benefits for targeted drug administration and controlled release applications. Tartaric acid sphere research and development have expanded as a result of the growing interest in creating novel medication delivery systems. The market is expanding as a result of investments made by research institutes and pharmaceutical corporations to investigate these fields' potential for different medications.

Growing Demand for Advanced Drug Delivery Systems

Manufacturers are focusing on novel formulations to enhance medication solubility, controlled release and stability, including implants, patches oral films and nanoparticles. Novartis has created cutting-edge ocular implants, such as OZURDEX, a sustained-release implant that offers extended medication release for ocular disorders.

To minimize systemic exposure and minimize adverse effects, manufacturers are developing devices that can transport medications directly to the site of action. For instance, companies such as Sun Pharmaceutical Industries have developed liposomal drug delivery methods that offer tailored delivery, particularly for cancer treatment while minimizing injury to healthy tissues.

Stringent Regulatory Framework

Strict regulations ensure that only medication delivery systems of the highest caliber, safety and effectiveness make it to market. Considering these rules builds confidence and trust with patients, stakeholders and healthcare professionals. The increases market expansion and acceptance of compliance products. To comply with regulations, producers must differentiate and innovate their products. Companies invest money in R&D to create cutting-edge medication delivery solutions that adhere to legal requirements. The results in the launch of cutting-edge, advanced technologies that provide them a competitive advantage in the marketplace.

Stricter rules frequently serve as entrance barriers for newer or less established businesses that could lack the means or expertise to comply with requirements. It can foster a working environment that supports innovation and propels market expansion by fostering the establishment of larger, more established companies with the required resources and expertise.

Sustainability and Green Initiatives

Sustainability objectives are aligned with the development of ecologically sustainable manufacturing procedures for tartaric acid spheres. One way to address consumer demand for eco-friendly products and improve market attractiveness is to develop efficient and low-impact production processes, follow green chemical concepts or use renewable resources.

Investigating biobased or biodegradable raw materials for the manufacturing of tartaric acid spheres can lessen reliance on sources generated from petrochemicals and help create a supply chain that is more sustainable. The transition to renewable resources is in line with sustainability goals and may draw in eco-aware customers.

The environment can benefit from green initiatives that aim to cut down on waste production, energy usage and emissions during the manufacturing of tartaric acid spheres. Companies can obtain a competitive advantage and access markets that value environmentally friendly products by implementing sustainable practices.

Segment Analysis

The global tartaric acid spheres market is segmented based on particle size, distribution channel, end-user and region.

Owing to Improved Stability and Controlled Release, Demand for Cosmetics and Personal Care Products

Cosmetics and personal care products' active components can be encapsulated in tartaric acid spheres. The stability and regulated release of reactive or sensitive components can be ensured by these spheres, improving the effectiveness of skincare, hair care and other beauty products.

The active components can be released gradually over time due to tartaric acid spheres' controlled release characteristics. The regulated release can improve the absorption and efficacy of moisturizers, antioxidants and vitamins in skincare products. Therefore, the cosmetics & personal care end-user segment is estimated to grow at a highest CAGR during the forecasting period.

Geographical Penetration

Technological Advancements and Regulatory Framework Propel Regional Growth

The regulatory authorities in North American countries are well-established and ensure the safety and quality requirements of the products. Adherence to these laws augments the legitimacy of tartaric acid spheres, hence propelling their acceptance across diverse industries and bolstering market expansion.

Due to the region's strong infrastructure for research and development, encapsulation and controlled release technologies are witnessing rapid technological developments. The promotes creativity and the development of tartaric acid spheres with enhanced qualities, which expands the market. As a result, during the projected time, North America is growing at a significant rate.

COVID-19 Impact Analysis

Reduced production capacities resulted from operational difficulties or temporary closures of numerous manufacturing sites. The had an impact on the market's supply of tartaric acid spheres, leading to shortages.

The demand for cosmetics and personal care items was impacted by changes in consumer expenditure and behavior during the pandemic. There have been changes in the demand for tartaric acid spheres used in these products due to the decreased emphasis on personal care and beauty routines, particularly during lockdowns. Production and distribution channels in industries like food, medicine and cosmetics were disrupted. Producers in these industries modified their plans and goals in reaction to the uncertainties surrounding the pandemic, this had an impact on the total demand for tartaric acid spheres.

Russia-Ukraine War Impact Analysis

Market volatility and uncertainty are frequently caused by geopolitical conflict. Trade barriers, geopolitical concerns and uncertain economic situations can all have an impact on investor confidence and consumer mood, which could then have an impact on tartaric acid product demand and price.

Trade disruptions, tariffs or sanctions against certain regions or countries involved are possible outcomes of geopolitical crises. The import and export of materials and goods associated to tartaric acid may be impacted by trade agreement modifications or restrictions, which could have an effect on market dynamics.

By Particle Size

  • 100-350 µm
  • 200-355 µm
  • 300-500 µm
  • 400-600 µm
  • 500-700 µm
  • 600-800 µm

By Distribution Channel

  • Direct Sales
  • Distributors/Wholesalers
  • Online Platforms/Retailers

By End-User

  • Pharmaceutical Manufacturing
  • Food Processing Industry
  • Cosmetics & Personal Care
  • Chemical Industry
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Russia
    • Rest of Europe
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • Rest of Asia-Pacific
  • Middle East and Africa

Key Developments

  • In 2023, Functional starter pellets are employed in the pharmaceutical production of oral solid dosage (OSD) medications to interact with the active component and achieve the desired drug release profile. While neutral beads don't interact with API, functional starting pellets serve a distinct purpose. In the pharmaceutical industry, tartaric acid is mostly used as an acidic ingredient in effervescent granules, powders and tablets. It is a benign and nonirritating substance that can be added to pharmaceutical formulations including bicarbonates.
  • In October 2022, The launch of the Vintera brand represents a clear new positioning for the Alvinesa portfolio in the high-value, branded and scientifically backed active ingredient arena. Alvinesa Natural Ingredients is expanding its globally health and nutrition ingredient business. Natural polyphenols, natural tartaric acid, natural colorings, grape seed oil and more upcoming cutting-edge releases are all part of Alvinesa's portfolio of natural ingredients. A crucial first step in the company's new strategic orientation is the launch of a brand for its ingredients.
  • In 2019, leading manufacturer of fine chemicals, ABB, has announced increasing its capacity to make tartaric acid. The expansion was launched to meet the growing demand for tartaric acid across many industries, such as cosmetics, food & beverage and medicines.

Competitive Landscape

The major global players in the market include Tate & Lyle plc, Merck KGaA, Neutral Spheres, Pharmatrans-Sanaq AG, Ingredient Pharm, Tarac Technologies, Tartaros Gonzalo Castello S.L and SPI Pharma.

Why Purchase the Report?

  • To visualize the global tartaric acid spheres market segmentation based on particle size, distribution channel, end-user and region, as well as understands key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of tartaric acid spheres market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Particle Size mapping available as excel consisting of key products of all the major players.

The global tartaric acid spheres market report would provide approximately 55 tables, 59 figures and 197 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Particle Size
  • 3.2. Snippet by Distribution Channel
  • 3.3. Snippet by End-User
  • 3.4. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Tartaric Acid Spheres Revolutionizing Drug Delivery Systems
      • 4.1.1.2. Growing Demand for Advanced Drug Delivery Systems
    • 4.1.2. Restraints
      • 4.1.2.1. Stringent Regulatory Framework
    • 4.1.3. Opportunity
      • 4.1.3.1. Sustainability and Green Initiatives
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. Russia-Ukraine War Impact Analysis
  • 5.6. DMI Opinion

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID
    • 6.1.2. Scenario During COVID
    • 6.1.3. Scenario Post COVID
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Particle Size

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Particle Size
    • 7.1.2. Market Attractiveness Index, By Particle Size
  • 7.2. 100-350 µm*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. 200-355 µm
  • 7.4. 300-500 µm
  • 7.5. 400-600 µm
  • 7.6. 500-700 µm
  • 7.7. 600-800 µm

8. By Distribution Channel

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 8.1.2. Market Attractiveness Index, By Distribution Channel
  • 8.2. Direct Sales*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Distributors/Wholesalers
  • 8.4. Online Platforms/Retailers

9. By End-User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.1.2. Market Attractiveness Index, By End-User
  • 9.2. Pharmaceutical Manufacturing*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Food Processing Industry
  • 9.4. Cosmetics & Personal Care
  • 9.5. Chemical Industry
  • 9.6. Others

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Particle Size
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Particle Size
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. UK
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Russia
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Particle Size
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Particle Size
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Particle Size
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

  • 12.1. Tate & Lyle plc*
    • 12.1.1. Company Overview
    • 12.1.2. Particle Size Portfolio and Description
    • 12.1.3. Financial Overview
    • 12.1.4. Key Developments
  • 12.2. Merck KGaA
  • 12.3. Neutral Spheres
  • 12.4. Pharmatrans-Sanaq AG
  • 12.5. Ingredient Pharm
  • 12.6. Tarac Technologies
  • 12.7. Tartaros Gonzalo Castello S.L
  • 12.8. SPI Pharma

LIST NOT EXHAUSTIVE

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us